anti-doping is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-07-23. Where a claim depends on a specific study, the study is described rather than over-claimed.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Derived from C-terminal region of human growth hormone |
| Approximate molecular mass | About 1.8 kDa | Varies with sequence length and counterions |
| Confirmed receptor target | None established | No confirmed growth hormone receptor agonism |
| Reported in vitro activity | Lipolysis stimulation and lipogenesis inhibition | Observed mainly in adipocyte models; human relevance uncertain |
| Regulatory status | Not approved as a drug in major markets | May be treated differently across jurisdictions; not a recognized dietary ingredient in some countries |
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Exhibitors from outside Tamil Nadu also echoed similar views. Arora Talkies (Mumbai) described Darbar as the most profitable Tamil film screened at their theatre, while exhibitors in Karnataka reported a favourable audience response. Several theatre owners dismissed circulating reports of losses as “rumours” and emphasised that the film delivered satisfactory returns at the exhibition level.
== Caveats == Several factors can affect the reliability of inter-country comparisons of resistance rates, due to differences in data quality and biased introduced during data collection and reporting. Several identified by EARS-Net are:
=== Isomerisation === The chiral centers of a polypeptide chain can undergo racemization. Although it does not change the sequence, it does affect the chemical properties of the sequence. In particular, the L-amino acids normally found in proteins can spontaneously isomerize at the
=== Glycoprotein Ib-IX-V complex (GPIb-IX-V) === This transmembrane glycoprotein complex is composed of four subunits: GPIbα, GPIbβ, GPV and GPIX. Each of them has a variable number of leucine-rich repeats. GPIbα and GPIbβ are linked by disulfide bridges, while the GPV and GPIX associate non-covalently with the complex. The GPIbα subunit bears the binding site for von Willebrand factor (vWF), α-thrombin, leukocyte integrin αMβ2 and P-selectin. The binding between GPIbα and vWF mediates the capture of platelets to the injured vascular wall. The deficiency in glycoprotein Ib-IX-V complex synthesis leads to Bernard–Soulier syndrome.
Sources: en.wikipedia.org
== January 29, 1982 (Friday) == The Philadelphia Bulletin published its final issue, after having been printed every day for 134 years. The farewell issue bore the headline "Goodbye: After 134 years, a Philadelphia voice is silent" Boater Steven Callahan departed from El Hierro, one of the Canary Islands, with a goal of crossing the Atlantic Oean toward Antigua, the larger island of the Caribbean nation of Antigua and Barbuda. He disappeared on February 5, 1982 and his fate was uncertain for 76 days as he survived alone in a life raft when his boat sank, before being rescued on April 20. Born: Riff Raff (stage name for Horst Simco), American rap artist; in Houston Adam Lambert, American singer and TV actor; in Indianapolis Panu Aaltio, Finnish film composer; in Nurmijärvi Died: Hironori Ōtsuka, 89, Japanese martial artist who created Wadō-ryū, one of the four major karate styles Sir Rudolph Peters, 92, British biochemist whose research team created the antidote for the chemical warfare poison lewisite Gabriel Fabella, 83, Philippine historian who successfully lobbied in 1962 for changing Philippine independence day from July 4 to June 12, based on the 1898 declaration of independence Palden Thondup Namgyal, 58, the last King of Sikkim prior to its 1973 annexation to India, died in New York City from complications of cancer surgery. Murtaza Ali Khan, 55, former heir apparent to the throne of the Nawab of the Indian princely state of Rampur prior to its annexation into the state of Uttar Pradesh
== Causes == Cirrhosis has many possible causes, and more than one cause may be present. History taking is of importance in trying to determine the most likely cause. Globally, 57% of cirrhosis is attributable to either hepatitis B (30%) or hepatitis C (27%). Alcohol use disorder is another major cause, accounting for about 20–40% of the cases.
In 1928, under Joseph Peter Grace's leadership, an agreement between Grace and Pan American formed Pan American-Grace Airways (or Panagra), a United States international carrier flying down the west coast of South America. Panagra ultimately evolved into a jet carrier flying from Miami and New York to South America before merging with Braniff Airways in 1967, becoming Braniff's South American network. These routes were sold to Eastern Air Lines in 1982 and then to American Airlines in 1990. In 1929, the vice president at that time, D. Stewart Inglehart, became president, and Joseph Peter Grace was elected chairman of the board of the company.In 1945, the founder's grandson and Joseph Peter Grace's son, J. Peter Grace, became president. Under his leadership, the company owned the country's largest oil-drilling fleet as of 1990-1993, managed its subsidiary Grace Cocoa, which was one of the world's leading suppliers of cocoa bean and chocolate ingredients as of 1992, as well as sugar plantations in Peru, cotton mills in Chile, silver, clay, phosphate, and tin mines. Through its Davison Chemical Division, the company had processed various nuclear materials under a contract from the United States Atomic Energy Commission (AEC). New companies such as Grace Petroleum, Grace Drilling, and Grace Healthcare were created under the umbrella of the Grace Corporation. Grace owned a food group that operated 900 chain restaurant locations, and a retail division with chains for sporting goods, home improvement, jewelry, aftermarket automotive parts and leather goods.
Sources: en.wikipedia.org
2 NaCN + Br2 → (CN)2 + 2 NaBr (CN)2 + Br2 → 2 BrCN When refrigerated the material has an extended shelflife. Like some other cyanogen compounds, cyanogen bromide undergoes an exothermic trimerisation to cyanuric bromide ((BrCN)3). This reaction is catalyzed by traces of bromine, metal salts, acids and bases. For this reason, experimentalists avoid brownish samples.
=== Economics === Economists have modeled the circumstances under which slavery (and variants such as serfdom) appear and disappear. One theoretical model is that slavery becomes more desirable for landowners where land is abundant, but labour is scarce, such that rent is depressed and paid workers can demand high wages. If the opposite holds true, then it is more costly for landowners to guard the slaves than to employ paid workers who can demand only low wages because of the degree of competition. Thus, first slavery and then serfdom gradually decreased in Europe as the population grew. They were reintroduced in the Americas and in Russia as large areas of land with few inhabitants became available. Slavery is more common when the tasks are relatively simple and thus easy to supervise, such as large-scale monocrops such as sugarcane and cotton, in which output depended on economies of scale. This enables systems of labour, such as the gang system in the United States, to become prominent on large plantations where field hands toiled with factory-like precision. Then, each work gang was based on an internal division of labour that assigned every member of the gang to a task and made each worker's performance dependent on the actions of the others. The slaves chopped out the weeds that surrounded the cotton plants as well as excess sprouts. Plow gangs followed behind, stirring the soil near the plants and tossing it back around the plants. Thus, the gang system worked like an assembly line.
== General == Human Development Index (2021): Thailand ranked 66 of 191 countries. Satisfaction with Life Index: Ranked 76 of 178 countries. Where-to-be-born Index: Thailand ranked 50 of 80 countries.
In the 1970s, Judi Sheppard Missett helped create the market for commercial aerobics with her Jazzercise program, at the same time as Jacki Sorensen was expanding her system of aerobic dancing. In the 1980s, Richard Simmons hosted an aerobic exercise show on television, and followed Jane Fonda's lead by releasing a series of exercise videos. In the 1990s, Billy Blanks's Tae Bo helped popularize cardio-boxing workouts that incorporated martial arts movements. Reebok shoes popularized step aerobics with their Reebok Step device and training program.
Sources: en.wikipedia.org
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.
It is not approved as a prescription drug in the United States or the European Union for any indication. Regulatory status can differ by country, and it is often sold as a research chemical or in unapproved products. Such products are not equivalent to an approved medicine.
In the studies reported so far, AOD9604 does not appear to act through the growth hormone receptor and has not shown the typical IGF-1 increase caused by full-length hGH. Human data are limited, so this remains an area of uncertainty. It should not be assumed to have the same effects as hGH.
Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.